Clinical Trials · NCT01388920
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Theratechnologies
- Enrollment
- 3
- Start date
- Sep 2011
- Locations
- See registry
- Primary endpoint
- Change From Baseline in Lean Body Mass at 6 Months